MedPro RRG
Major Rating Factors:
Fair long-term capitalization index (4.3 on a scale of 0 to 10) based on good current risk adjusted capital (severe loss scenarios) reflecting some improvement over results in 2021. Fair overall results on stability tests (3.0) including negative cash flow from operations for 2024 and fair risk adjusted capital in prior years. The largest net exposure for one risk is excessive at 10.2% of capital. Strengths include potentially strong support from affiliation with Berkshire Hathaway Inc. Good overall profitability index (5.5) despite operating losses during 2020, 2021 and 2024. Return on equity has been low, averaging 3.5% over the past five years.
Other Rating Factors:
Ample reserve history (7.0) that can protect against increases in claims costs. Vulnerable liquidity (2.8) as a spike in claims may stretch capacity.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
F - Negative cash flow.
L - Past results on our liquidity tests.
R - Concerns about the financial strength of its reinsurers.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (95.5%), other (4.5%)
Licensed in:
DC
Principal Investments:
Cash (10.4%), other (89.6%)
Corporate Info
Group Affiliation
Berkshire Hathaway Inc
Investment Rating
--
Company Address
1500 K Street, NW
Washington, DC 20005
Washington, DC 20005
Phone Number
(202) 842-8800
NAIC Number
13589
Largest Affiliates